EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2024

Disclosure of Share Capital and Voting Rights Outstandingas of July 31, 2024(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)Charenton-le-Pont, France (August 29, 2024 - 6:00 pm)– As of July 31, 2024, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks...
Comunicato Precedente

next
Comunicato Successivo

next
Charenton Cedex, (informazione.it - comunicati stampa - salute e benessere)

Disclosure of Share Capital and Voting Rights Outstanding
as of July 31, 2024

(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Charenton-le-Pont, France (August 29, 2024 - 6:00 pm) – As of July 31, 2024, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.

  July 31, 2024
Shares outstanding 457,320,9271
Number of real voting rights (excluding treasury shares) 455,577,543
Theoretical number of voting rights (including treasury shares) 457,320,927

It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained in article 23 of EssilorLuxottica's by-laws2.

For further information, please consult the Prospectus which received Visa No. 18-460 from the AMF on September 28, 2018 and its Securities Note Supplement which received Visa No. 18-494 from the AMF on October 23, 2018, available on the website www.essilorluxottica.com.

1Including 2,636shares delivered but not yet registered as of July31, 2024.
2EssilorLuxottica's by-laws are available on the Company's website under the section Governance / Publications.

Attachment


Per maggiori informazioni
Sito Web
essilor.com
Ufficio Stampa
 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
Allegati
Slide ShowSlide Show
Non disponibili